Atlas Trials

Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study

Clinical trial NCT05089916 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05089916
Sponsor
AIO-Studien-gGmbH
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLCEGFR Positive Non-small Cell Lung CancerOligoprogression
Start date
2022-01-20
Primary completion
2026-03-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.